| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.22 | 9e-05 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.16 | 9e-05 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0006 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0006 |